[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555183":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":39,"centralContacts":44,"locations":51,"responsibleParty":119,"collaborators":49,"id":121,"slug":122,"hasResults":123,"nctId":124,"briefTitle":125,"officialTitle":125,"acronym":126,"eligibilityCriteria":127,"healthyVolunteers":123,"sex":128,"minAge":49,"maxAge":49,"enrollmentInfo":129,"targetDuration":49,"studyType":132,"phases":133,"briefSummary":135,"conditions":136,"keywords":49,"overallStatus":54,"whyStopped":49,"lastUpdateSubmitDate":144,"lastUpdatePostDateStruct":145,"startDateStruct":148,"completionDateStruct":150,"leadSponsor":152,"locationsCount":153},{"fullName":5,"class":6},"Miltenyi Biomedicine GmbH","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Long-term follow-up of CAR T cell therapy","EXPERIMENTAL","Assessment of long-term safety and efficacy of Miltenyi CAR T treatment.",[13,14,15],"Biological: MB-CART19.1","Biological: MB-CART20.1","Biological: MB-CART2019.1",[17,25,32],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":22},"BIOLOGICAL","MB-CART19.1","Assessment of long-term safety and efficacy of MB-CART19.1 treatment.",[9],[23,24],"CD19-targeting CAR T cells","Anti-CD19 CAR T cells",{"type":18,"name":26,"description":27,"armGroupLabels":28,"otherNames":29},"MB-CART20.1","Assessment of long-term safety and efficacy of MB-CART20.1 treatment.",[9],[30,31],"CD20-targeting CAR T cells","Anti-CD20 CAR T cells",{"type":18,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"MB-CART2019.1","Assessment of long-term safety and efficacy of MB-CART2019.1 treatment.",[9],[37,38],"CD20\u002FCD19-targeting CAR T cells","Anti-CD20\u002FCD19 CAR T cells",[40],{"name":41,"affiliation":42,"role":43},"Claudia Rössig, Prof. Dr.","Universitätsklinikum Münster","PRINCIPAL_INVESTIGATOR",[45],{"name":46,"role":47,"phone":48,"phoneExt":49,"email":50},"Clinical Trial Manager","CONTACT","+4922048306820",null,"clinicaltrials.gov@miltenyi.com",[52,65,75,84,93,101,110],{"facility":53,"status":54,"city":55,"state":49,"zip":56,"country":57,"countryCode":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":49},"Charité Universitätsmedizin Berlin","RECRUITING","Berlin","13353","Germany","DE",{"type":60,"coordinates":61},"Point",[62,63],13.41053,52.52437,{"lat":63,"lon":62},{"facility":66,"status":67,"city":68,"state":49,"zip":69,"country":57,"countryCode":58,"cosmosGeoPoint":70,"geoPoint":74,"contacts":49},"Universitätsklinikum Köln","ACTIVE_NOT_RECRUITING","Cologne","50937",{"type":60,"coordinates":71},[72,73],6.95,50.93333,{"lat":73,"lon":72},{"facility":76,"status":67,"city":77,"state":49,"zip":78,"country":57,"countryCode":58,"cosmosGeoPoint":79,"geoPoint":83,"contacts":49},"Uniklinikum Erlangen","Erlangen","91054",{"type":60,"coordinates":80},[81,82],11.00783,49.59099,{"lat":82,"lon":81},{"facility":85,"status":67,"city":86,"state":49,"zip":87,"country":57,"countryCode":58,"cosmosGeoPoint":88,"geoPoint":92,"contacts":49},"Universitätsmedizin Göttingen","Göttingen","37075",{"type":60,"coordinates":89},[90,91],9.93228,51.53443,{"lat":91,"lon":90},{"facility":42,"status":54,"city":94,"state":49,"zip":95,"country":57,"countryCode":58,"cosmosGeoPoint":96,"geoPoint":100,"contacts":49},"Münster","48149",{"type":60,"coordinates":97},[98,99],7.62571,51.96236,{"lat":99,"lon":98},{"facility":102,"status":67,"city":103,"state":49,"zip":104,"country":57,"countryCode":58,"cosmosGeoPoint":105,"geoPoint":109,"contacts":49},"Universitätsklinikum Tübingen","Tübingen","72076",{"type":60,"coordinates":106},[107,108],9.05222,48.52266,{"lat":108,"lon":107},{"facility":111,"status":67,"city":112,"state":49,"zip":113,"country":57,"countryCode":58,"cosmosGeoPoint":114,"geoPoint":118,"contacts":49},"Universitäts-Kinderklinik Würzburg","Würzburg","97080",{"type":60,"coordinates":115},[116,117],9.95121,49.79391,{"lat":117,"lon":116},{"type":120,"investigatorFullName":49,"investigatorTitle":49,"investigatorAffiliation":49,"oldNameTitle":49,"oldOrganization":49},"SPONSOR","100555183","long-term-follow-up-of-patients-treated-with-miltenyi-cell-and-gene-therapies-100555183",false,"NCT06508775","Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies","LONGSAFE","Inclusion Criteria:\n\n* Patient underwent treatment with a Miltenyi CAR T cell therapy in one of the parent trials at least 12 months prior to enrollment in long-term follow-up.\n* Patient has provided informed consent prior to enrollment.\n\nExclusion Criteria:\n\n* No exclusion criteria","ALL",{"count":130,"type":131},40,"ESTIMATED","INTERVENTIONAL",[134],"NA","The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.",[137,138,139,140,141,142,143],"Melanoma Stage III","B-cell Non Hodgkin Lymphoma","Pediatric ALL","Childhood Non-Hodgkin Lymphoma","Acute Lymphatic Leukemia","Chronic Lymphatic Leukemia","Melanoma Stage IV","2025-11-20",{"date":146,"type":147},"2025-11-26","ACTUAL",{"date":149,"type":147},"2024-05-05",{"date":151,"type":131},"2040-12-31",{"name":5,"class":6},7]